A degree in Marketing, Communications or Business, with previous work experience in biotechnology, medical devices, or pharmaceutical industry is also…From Thermo Fisher Scientific – Wed, 01 Dec 2021 06:18:11 GMT – View all San Diego, […]
Sorrento Therapeutics (“Sorrento”) is currently looking for highly motivated individuals with extensive expertise in molecular and cellular Immunology to join…From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View all San Diego, CA […]
The position offers a unique opportunity for a candidate with expertise in synthetic and medicinal chemistry to lead and provide key contributions to design,…From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View […]
Sorrento Therapeutics (“Sorrento”) is currently looking for a experienced Research Associate. The candidate will participate in pre-clinical in-vivo and in…From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View all San Diego, CA […]
Sorrento's multimodal multipronged approach to fighting cancer is made possible by its' extensive immuno-oncology platforms, including key assets such as fully…From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View all San Diego, […]
Sorrento Therapeutics (“Sorrento”) is seeking an experienced Scientist/Process Development and Manufacturing Associate who will be responsible for process…From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View all San Diego, CA jobsClick here […]
A successful candidate will support therapeutic protein engineering efforts through antibody/protein design, cloning, expressing and in vitro characterization.From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View all San Diego, CA jobsClick here […]
Hologic’s grant money will also back STEM education, social and racial equity initiatives in local communities. Click here to view original post… […]
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technologies that may provide new hope for those in severe pain, today announced the completion of a positive safety review and enrollment of the… Click here to view original post… […]
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming conference: Click here to view original post… […]
Experience with process mapping and legacy is preferred • Minimum of 5 years of professional work experience with relevant commercial/data management and…From Indeed – Wed, 01 Dec 2021 00:11:30 GMT – View all San Diego, […]
The Senior Research Associate II plays an active role in planning of projects and experiments and is often the technical lead responsible for the successful…From Exact Sciences Corporation – Tue, 30 Nov 2021 23:56:37 GMT […]
SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced the closing of its previously announced private placement of equity. The Company received gross proceeds of… Click here to view original post… […]
SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it plans to offer 17,500,000 shares of its common stock in an underwritten public offering. In connection with the offering, the Company intends to grant the underwriters a 30-day… Click here to view original post… […]
The San Diego Supercomputer Center has a new director. Frank Würthwein, lead of SDSC’s Distributed High-Throughput Computing Group, executive director of the Open Science Grid, a physics professor and a founding… […]
UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a naturally efficient vehicle for delivering genetic material such as RNA inside cells. Click here to view original post… […]
UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a natu… […]
SAN DIEGO and ADELAIDE, Australia: SAN DIEGO and ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the official opening of its new biologics manufacturing facility in Adelaide, Australia…. Click here to view original post… […]
LA JOLLA—In the classic “Rubin’s vase” optical illusion, you can see either an elaborate, curvy vase or two faces, noses nearly touching. At any given moment, which scene you perceive depends on whether your brain is viewing the central vase shape to be the foreground or background of the picture…. Click here to view original post… […]
CARLSBAD, Calif.: CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen TrueCut HiFi Cas9 Protein* significantly minimizes off-target events while retaining maximum on-target editing efficiency. Thermo Fisher Scientific introduced the… Click here to view original post… […]
SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research (GCAR) registrational Phase 2/3 clinical… Click here to view original post… […]
SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) today reported a successful Type C meeting with the U.S. Food and Drug Administration in which agreement was reached on the preliminary submission strategy for EVO100 for two investigational indications: the prevention of urogenital chlamydia in… Click here to view original post… […]
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that restoration of retinal tissue was observed in a fourth patient enrolled in the Company’s Phase 1/2a clinical study of its lead product… Click here to view original post… […]
SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet needs, today announced the appointment of Marty Lorenzo as General Counsel. Mr. Lorenzo brings over 20 years in the legal profession leading corporate… Click here to view original post… […]
Thanks in part to interest from Big Pharma players like Bayer and Novartis over the last decade, there’s been no shortage in cash for new companies looking to slay tumor cells with targeted radioisotopes. Now a transpacific upstart has hooked $75 million to bring the increasingly popular drugs to China…. Click here to view original post… […]
SAN DIEGO and SHANGHAI: SAN DIEGO and SHANGHAI, Nov. 30, 2021 /PRNewswire/ — ABM Therapeutics (ABM), a clinical-stage biopharmaceutical company with a focus on treating brain cancers and cancer metastases, today announced that its IND application for ABM-1310, a new-generation BRAF inhibitor, has been approved by the National Medical Products… Click here to view original post… […]
1+ years of industry experience in a biotechnology environment. We are seeking a motivated and self-directed individual to support a variety of lab support…From Illumina – Tue, 30 Nov 2021 06:11:30 GMT – View all […]
Blueprint Medicines could pay an additional $215 million if Lengo’s experimental treatment hits regulatory and sales targets. Click here to view original post… […]
SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the commercial launch of its BioXp™ mRNA synthesis kits with CleanCap® Reagent AG, a proprietary mRNA capping technology from TriLink BioTechnologies, part of Maravai LifeSciences (NASDAQ: MRVI)…. Click here to view original post… […]
SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced the publication of a Teaser titled “Abivertinib – a Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases” (“Abivertinib Teaser”). Sorrento intends to use the Abivertinib Teaser to engage in discussions with interested third… Click here to view original post… […]
Copyright © 2023 Biotech Networks, LLC
